• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Assays - Articles and news items

IntelliCyt Cy-Clone™ PLUS

IntelliCyt launches novel assay system to accelerate cell line development

Supplier news / 3 April 2017 / IntelliCyt

The IntelliCyt Cy-Clone™ PLUS Assay System will accelerate and improve the quality of clone ranking and selection for developing cell lines which can reduce production costs of biopharmaceuticals…

Biocartis and Merck partnership launch second liquid biopsy assay

Industry news / 15 March 2017 / Niamh Marriott, Junior Editor

This collaboration is aimed at jointly developing and commercialising new liquid biopsy RAS biomarker tests for metastatic colorectal cancer (mCRC)…

Ovarian assay

FDA approves Roche’s assay to assess ovarian reserve

Industry news / 10 January 2017 / Niamh Marriott, Digital Editor

The blood test produces standardised results for assessing ovarian reserve as compared with the use of vaginal ultrasound…

Biocartis launches second liquid biopsy assay

Industry news / 14 December 2016 / Niamh Louise Marriott, Digital Editor

Biocartis launched its second liquid biopsy assay, the Idylla ctKRAS Mutation Assay, which was developed in partnership with Merck…

Quantification of Tablets Containing Multiple APIs: Using Transmission Raman

Whitepapers / 25 October 2016 / Cobalt Light Systems

The ability to predict multiple constituents of a final dosage form in one fast, non-destructive measurement can reduce analysis time. This is especially important when quantification of multiple APIs is required for tests such as content uniformity, assay and ID…

Celltrion to develop assay for evidence-based decision-making in anti-TNF treatment

Industry news / 5 July 2016 / Victoria White, Digital Content Producer

Celltrion is to develop laboratory tests that will enable physicians to identify when patients on an anti-TNF drug require a change of dose…

DiscoverX launches KILR™ assay platform for use in cancer immunotherapy drug development

Supplier news / 30 March 2016 / DiscoverX Corporation

DiscoverX Corporation has launched the KILR Retroparticles product line, providing scientists complete flexibility to develop a simple cytotoxicity assay in almost any cell line…

Drug discovery assays for the histone deacetylase class of enzymes

Easily measure cancer cell death in a co-culture with KILR™ Assays from DiscoverX

Supplier news / 2 February 2016 / DiscoverX

DiscoverX Corporation announced the launch of the KILR Cytotoxicity Assay, a pioneering approach to accelerate the development of cancer immunotherapy drugs…


Accelerate development of Cancer Immunotherapy (iOnc) drugs with new PathHunter® Checkpoint Assays from DiscoveRx

Supplier news / 14 January 2016 / DiscoveRx

DiscoveRx Corporation announced the expansion of its PathHunter cell-based assays portfolio with the release of PathHunter Checkpoint Assays…

New UV-Vis Spectrophotometer simplifies sample quality decisions

New UV-Vis Spectrophotometer simplifies sample quality decisions

Supplier news / 22 October 2015 / Thermo Fisher Scientific

Thermo Scientific NanoDrop One spectrophotometers designed to identify contaminants, providing accurate concentrations…

Development of biosensor assays for fragment screening of wild type GPCRs

Webinars / 14 October 2015 /

In this webinar, we discuss SPR fragment screening of wild type GPCRs enabled by sensitive biosensors and optimised membrane protein assays…

Increasing Throughput and Sensitivity of LC-MS assays with a focus on MS optimisation and novel LC strategies

Webinars / 13 July 2015 / Sciex

Simplifying peptide quantification with automated optimisation of MRM transitions and advantages of Micro flow LC to maximise LC-MS performance…

  • Page 1 of 2
  • 1
  • 2
  • >